Dr. Sherman Sol Fox

M.D. | Neurology - Neurodevelopmental Disabilities | 52+ years Exp


  65 Newbury St, Danvers
     Massachusetts, 01923-1040
  978-750-6828    978-750-6684 Maps & Directions
Dr. Sherman Sol Fox is a Danvers, Massachusetts based neurologist with 52 years of experience in Neurodevelopmental Disabilities. He completed his graduation from George Washington University School Of Medicine in 1972. He is also affiliated with hospitals like and . He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Sherman Sol Fox is 159298 for Neurodevelopmental Disabilities in Massachusetts. His current practice location is 65 Newbury St, Danvers. Patients can reach him at 978-750-6828 or can fax him at 978-750-6684. Dr. Sherman Sol Fox is M.D. in Neurodevelopmental Disabilities and his NPI number (Unique professional ID assigned by NPPES) is 1447312814.
Dr. Sherman Sol Fox specializes in the diagnosis and management of chronic conditions that affect the developing and mature nervous system such as cerebral palsy, mental retardation and chronic behavioral syndromes, or neurologic conditions.
Complete Profile:
Dr. Sherman Sol Fox speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Sherman Sol Fox
Specialization: Neurodevelopmental Disabilities
Gender:Male
Credentials: M.D.
Experience: 52+ years
Medical School Attended:George Washington University School Of Medicine
Graduation Year:1972
Accepts Medicare Assignment:Yes
Practice Address:65 Newbury St, Danvers,
Massachusetts, 01923-1040
Phone:978-750-6828
Fax:978-750-6684
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 4082659024
Enrollment ID: I20050621000837
NPI Number: 1447312814
NPI Enumeration Date: 14 Dec, 2006
NPI Last Update On: 08 Jul, 2007

Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Sherman Sol Fox are as mentioned below.
License NumberSpecializationStateStatus
159298Neurodevelopmental Disabilities MassachusettsPrimary
6027Neurodevelopmental Disabilities New HampshireSecondary
0008042Neurodevelopmental Disabilities VermontSecondary
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN) State Hospital Type
(220035)Salem, MAAcute Care Hospital
(220070)Melrose, MAAcute Care Hospital
(220063)Lowell, MAAcute Care Hospital
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Dr. Sherman Sol Fox is associated with along with the number of members in that group.
Organization Name (Group PAC ID) Members
Monadnock Family Services (4587681978)7
Bridgewell, Inc (6507833985)18
Other Medical Identifiers:
Other legacy medical identifiers associated with Dr. Sherman Sol Fox such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
1001038MedicaidVermont
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Sherman Sol Fox
1030 Upper Dummerston Rd,
Brattleboro, Vermont
Zip: 05301-8814
Phone Number: 781-302-4746
Fax Number: 781-302-4635
Patients can reach Dr. Sherman Sol Fox at 65 Newbury St, Danvers, Massachusetts or can call to book an appointment on 978-750-6828.
Comments/ Reviews:

*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.